HeartBeam, Inc. (NASDAQ:BEAT) Q1 2025 Earnings Call Transcript
HeartBeam, Inc. (NASDAQ:BEAT) Q1 2025 Earnings Call Transcript May 13, 2025HeartBeam, Inc. misses on earnings expectations.
Posts Tagged ‘(NASDAQ:BEAT)’
HeartBeam, Inc. (NASDAQ:BEAT) Q4 2024 Earnings Call Transcript
Operator: Greetings, and welcome to the HeartBeam, Inc. Fourth Quarter and Full Year 2024 Financial Results Conference Call.
10 Best Autonomous Driving Stocks To Buy According to Hedge Funds
The vision of fleets of driverless cars seamlessly transporting passengers has captivated consumers and driven billions in investment over recent years.
HeartBeam, Inc. (NASDAQ:BEAT) Q3 2024 Earnings Call Transcript
Operator: Greetings, and welcome to the HeartBeam Third Quarter 2024 Financial Results Conference Call.
HeartBeam, Inc. (BEAT): A Bull Case Theory
We came across a bullish thesis on HeartBeam, Inc. (BEAT) on Triple S Special Situations Investing’s Substack by TripleS Special Situations.
HeartBeam, Inc. (NASDAQ:BEAT) Q2 2024 Earnings Call Transcript
Operator: Greetings, and welcome to the HeartBeam Second Quarter 2024 Financial Results Conference Call. At this time, all participants are in a listen-only mode.
HeartBeam, Inc. (NASDAQ:BEAT) Q1 2024 Earnings Call Transcript
Operator: Greetings. And welcome to the HeartBeam First Quarter 2024 Financial Results Conference Call. At this time, all participants are in a listen-only mode.
HeartBeam, Inc. (NASDAQ:BEAT) Q4 2023 Earnings Call Transcript
HeartBeam, Inc. misses on earnings expectations. Reported EPS is $-0.15 EPS, expectations were $-0.12.
HeartBeam, Inc. (NASDAQ:BEAT) Q3 2023 Earnings Call Transcript
Operator: Greetings and welcome to the HeartBeam Third Quarter 2023 Financial Results Conference Call.
HeartBeam, Inc. (NASDAQ:BEAT) Q2 2023 Earnings Call Transcript
Operator: Greetings and welcome to the HeartBeam Second Quarter 2023 Financial Results Conference Call.
HeartBeam, Inc. (NASDAQ:BEAT) Q1 2023 Earnings Call Transcript
Operator: Greetings and welcome to the HeartBeam First Quarter 2023 Financial Results Conference Call. At this time all participants are in listen only mode.
HeartBeam, Inc. (NASDAQ:BEAT) Q4 2022 Earnings Call Transcript
Operator: Greetings. And welcome to the HeartBeam Fourth Quarter and Full-Year 2022 Financial Results Conference Call.
Is BEAT A Good Stock To Buy Now?
At Insider Monkey, we pore over the filings of nearly 817 top investment firms every quarter, a process we have now completed for the latest reporting period.
Is BioTelemetry, Inc. (BEAT) A Good Stock To Buy?
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Hedge Funds Are Selling BioTelemetry, Inc. (BEAT)
We hate to say this but, we told you so.
Should You Buy BioTelemetry, Inc. (BEAT)?
We are still in an overall bull market and many stocks that smart money investors were piling into surged through the end of November.
Were Hedge Funds Right About Dumping BioTelemetry, Inc. (BEAT)?
A whopping number of 13F filings filed with U.S.
Here’s What Hedge Funds Think About BioTelemetry, Inc. (BEAT)
Hedge fund managers like David Einhorn, Bill Ackman, or Carl Icahn became billionaires through reaping large profits for their investors, which is why piggybacking their stock...
Should You Buy BioTelemetry, Inc. (BEAT)?
Looking for stocks with high upside potential? Just follow the big players within the hedge fund industry. Why should you do so? Let’s take a brief look at what statistics ...
37 Major Stories Summarizing What’s Happening In The Financial Markets Today
"U.S. stock benchmarks on Thursday were switching between small gains and losses, as the energy sector tumbled in sync with a drop in crude oil.
Hedge Funds Are Crazy About BioTelemetry, Inc. (BEAT)
We have been waiting for this for a year and finally the third quarter ended up showing a nice bump in the performance of small-cap stocks.
How Did Cannell Capital’s Investments in Callon Petroleum Company (CPE), Cardionet Inc (BEAT) & Two Other Stocks Performed?
There were 659 hedge funds in our system whose 13F portfolios on June 30 consisted of at least five long positions in billion-dollar companies.
Here’s Why Catalyst Pharmaceuticals, Resolute Energy, Nutanix & Two Other Stocks Are Trading Higher Today
The markets have shaken off their negative trend as major indices are trading in the green zone.
Here is What Hedge Funds Think About BioTelemetry, Inc. (BEAT)
Investing in small cap stocks has historically been a way to outperform the market, as small cap companies typically grow faster on average than the blue chips.
Activist Cannell Capital Loves Micro-Caps
Activist investor J. Carlo Cannell leads his fund Cannell Capital in a non-conventional way. Cannell established his fund in 1992 with just $600,000.
Five Stock Picks From Hedge Fund Sophrosyne Capital
Sophrosyne Capital is a multi strategy hedge fund founded in 2005. The firm has about $200 million in assets under management and is based in New York, NY.
CardioNet/BioTelemetry Cut By Benjamin J. Taylor’s Hedge Fund
CardioNet/BioTelemetry: CardioNet, Inc. is yet another company that has been recently downsized in the equity portfolio of a hedge fund.
Hedge Funds Are Betting On Cardionet Inc (BEAT)
Is Cardionet Inc (NASDAQ:BEAT) a superb investment right now? Prominent investors are taking an optimistic view.
Do Hedge Funds and Insiders Love Cardionet Inc (BEAT)?
In today’s marketplace, there are a multitude of methods shareholders can use to analyze Mr. Market.
